A Ferrosilicon Latent Heat Thermophotovoltaic Battery
THERMOBAT aims to develop a cost-effective, high-density Latent Heat Thermophotovoltaic battery for long-duration energy storage and CHP generation, advancing towards commercialization and market readiness.
Projectdetails
Introduction
THERMOBAT will develop an innovative Latent Heat Thermophotovoltaic (LHTPV) battery for long duration storage (10 to 100 hours) and combined heat and power (CHP) generation.
Technology Overview
The system stores electricity in the form of latent heat at very high temperatures (1200 deg C) using a new kind of ferrosilicon alloy with very high energy density (> 1 MWh per m3). It converts this stored energy back to electricity and low-temperature heat (< 70 deg C) on-demand using solid-state Thermophotovoltaic (TPV) devices.
Value Proposition
The value proposition includes:
- A very cheap system (< 10 Euro per kWh)
- Very high energy density (> 400 kWh per m3)
- High global efficiency (> 90 %)
- Safety
- Flexibility
- Compact design
- Silent operation
- Recyclability
- Scalability
- Capability to produce clean heat and electricity on demand
Demonstration Project
The dispatchable CHP generation capability of the LHTPV battery will be demonstrated in a sports center managed by one of the largest Spanish companies dedicated to the design, maintenance, and operation of infrastructures.
Project Background
THERMOBAT builds on the results (demonstrated proof of principle) achieved within the FET-OPEN project AMADEUS, in which a small lab-scale prototype of the system was built and tested.
Commercialization Efforts
THERMOBAT will bring LHTPV technology closer to commercialization by developing scalable, low-cost, and environmentally friendly processes for the manufacturing of the key components of the LHTPV battery.
Tech-to-Market Strategy
In addition, we will focus on accelerating tech-to-market activities through Thermophoton, a recently established UPM spin-off company. This company will receive UPM's know-how and will develop a detailed business plan to make the innovation fully marketable.
Related Projects
This tech-to-market plan is also a continuation of another EU funded project named NATHALIE (FET Innovation Launchpad), in which the market and the potential application of the invention on industrial, commercial, and institutional buildings have been analyzed.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.575.920 |
Totale projectbegroting | € 2.575.920 |
Tijdlijn
Startdatum | 1-6-2022 |
Einddatum | 31-5-2026 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- UNIVERSIDAD POLITECNICA DE MADRIDpenvoerder
- NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU
- FOSECO NEDERLAND BV
- THERMOPHOTON SL
- ENTECH ENERGITEKNIK AB
- FERROGLOBE INNOVATION SL
- SERVEO SERVICIOS SA
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Medium to long term thermal energy storage system with embedded heat pumping capabilityDevelop a medium-temperature Thermal Energy Storage System to enhance energy efficiency and decarbonize the manufacturing sector by utilizing waste heat and improving sector coupling. | EIC Pathfinder | € 3.145.242 | 2023 | Details |
Integrated Thermal energy Storages for Zero Emission BuildingsThe LIFE iTS4ZEB project aims to develop and demonstrate innovative thermal energy storage technologies using phase change materials and heat pumps to enhance energy efficiency in residential buildings across Europe. | LIFE SAP | € 1.994.058 | 2023 | Details |
For Tunable Thermochemical Energy Storage4TunaTES aims to develop a flexible Thermo-Chemical Energy Storage technology that adapts to various applications, reducing R&D costs by 90% and unlocking thermal energy storage potential. | EIC Pathfinder | € 2.779.713 | 2024 | Details |
All in One: Harvesting of waste heat with solid thermal batteryDeveloping an all-solid-state thermal battery that utilizes H+ transport for efficient energy storage from waste heat across a wide temperature range, enhancing practical applications. | EIC Pathfinder | € 2.999.791 | 2024 | Details |
Medium to long term thermal energy storage system with embedded heat pumping capability
Develop a medium-temperature Thermal Energy Storage System to enhance energy efficiency and decarbonize the manufacturing sector by utilizing waste heat and improving sector coupling.
Integrated Thermal energy Storages for Zero Emission Buildings
The LIFE iTS4ZEB project aims to develop and demonstrate innovative thermal energy storage technologies using phase change materials and heat pumps to enhance energy efficiency in residential buildings across Europe.
For Tunable Thermochemical Energy Storage
4TunaTES aims to develop a flexible Thermo-Chemical Energy Storage technology that adapts to various applications, reducing R&D costs by 90% and unlocking thermal energy storage potential.
All in One: Harvesting of waste heat with solid thermal battery
Developing an all-solid-state thermal battery that utilizes H+ transport for efficient energy storage from waste heat across a wide temperature range, enhancing practical applications.